AtriCure (ATRC) stock price, revenue, and financials

AtriCure market cap is $1.2 b, and annual revenue was $201.63 m in FY 2018

$1.2 B

ATRC Mkt cap, 10-Jun-2019

$58.9 M

AtriCure Revenue Q2, 2019
AtriCure Gross profit (Q2, 2019)43.9 M
AtriCure Gross profit margin (Q2, 2019), %74.5%
AtriCure Net income (Q2, 2019)-4.1 M
AtriCure EBIT (Q2, 2019)-3.8 M
AtriCure Cash, 30-Jun-201925.2 M
AtriCure EV1.2 B

AtriCure Revenue

AtriCure revenue was $201.63 m in FY, 2018

Embed Graph

AtriCure Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

81.9m107.5m129.8m155.1m174.7m201.6m

Revenue growth, %

31%21%20%

Cost of goods sold

22.3m31.7m36.9m44.0m48.6m54.5m

Gross profit

59.6m75.8m92.9m111.1m126.2m147.1m

Gross profit Margin, %

73%70%72%72%72%73%

R&D expense

25.7m35.8m34.1m34.7m

General and administrative expense

93.9m106.4m117.0m129.5m

Operating expense total

119.6m142.2m151.1m164.2m

EBIT

10.9m(16.4m)(26.7m)(31.1m)(25.0m)(17.1m)

EBIT margin, %

13%(15%)(21%)(20%)(14%)(8%)

Interest expense

566.0k305.0k292.0k1.8m2.3m4.6m

Interest income

16.0k96.0k190.0k227.0k227.0k1.0m

Pre tax profit

(27.2m)(33.3m)(26.9m)(20.9m)

Income tax expense

18.0k(33.0k)(36.0k)40.0k14.0k226.0k

Net Income

(11.5m)(16.2m)(27.2m)(33.3m)(26.9m)(21.1m)

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Revenue

20.1m24.8m26.5m26.7m29.9m32.6m31.4m35.9m39.7m38.3m41.3m45.2m42.2m47.0m51.8m54.0m58.9m

Cost of goods sold

5.5m7.2m7.7m7.8m8.2m9.5m8.9m10.0m10.9m10.9m11.3m12.7m11.2m12.5m13.7m14.0m14.1m15.0m

Gross profit

14.7m17.7m18.8m18.9m21.7m23.1m22.5m25.9m28.8m27.5m30.0m32.6m30.9m34.5m38.1m39.9m43.9m

Gross profit Margin, %

73%71%71%71%73%71%72%72%73%72%73%72%73%73%74%74%75%

R&D expense

3.2m4.0m4.6m5.0m5.6m5.9m6.5m8.6m9.1m8.3m9.6m8.9m8.0m9.1m8.7m8.6m8.2m9.8m

General and administrative expense

14.1m21.6m17.1m14.7m21.3m22.1m22.1m26.8m27.4m25.5m30.1m30.0m29.8m34.9m28.5m33.4m37.0m37.9m

Operating expense total

17.3m25.6m21.6m19.7m26.9m27.9m28.6m35.3m36.6m33.8m39.7m38.9m37.8m43.9m37.1m42.0m45.2m47.7m

EBIT

(2.6m)(7.9m)(2.9m)(803.0k)(5.1m)(4.8m)(6.1m)(9.4m)(7.7m)(6.3m)(9.6m)(6.4m)(6.8m)(9.4m)958.0k(6.0m)(5.3m)(3.8m)

EBIT margin, %

(13%)(32%)(11%)(3%)(17%)(15%)(19%)(26%)(20%)(16%)(23%)(14%)(16%)(20%)2%(10%)(7%)

Interest expense

123.0k237.0k29.0k24.0k18.0k17.0k16.0k259.0k477.0k530.0k554.0k564.0k576.0k820.0k1.2m1.2m862.0k879.0k

Interest income

2.0k14.0k23.0k27.0k43.0k43.0k56.0k39.0k60.0k67.0k54.0k48.0k58.0k76.0k123.0k151.0k720.0k636.0k

Pre tax profit

(2.7m)(7.7m)(2.7m)(462.0k)(4.9m)(6.1m)(9.7m)(8.2m)(6.8m)(10.2m)(6.9m)(7.2m)(10.1m)(290.0k)(7.2m)(5.6m)(4.1m)

Income tax expense

4.0k27.0k5.0k4.0k6.0k8.0k6.0k5.0k17.0k2.0k23.0k17.0k26.0k48.0k48.0k51.0k66.0k10.0k

Net Income

(2.7m)(7.7m)(2.7m)(466.0k)(5.3m)(4.9m)(6.1m)(9.7m)(8.2m)(6.8m)(10.2m)(6.9m)(7.2m)(10.1m)(338.0k)(7.2m)(5.6m)(4.1m)

AtriCure Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

14.9m28.4m23.8m24.2m21.8m32.2m

Accounts Receivable

Inventories

10.2m14.3m17.7m17.7m22.5m22.5m

Current Assets

52.5m93.5m74.8m85.7m82.3m174.7m

PP&E

5.6m11.6m31.3m30.0m28.7m27.1m

Goodwill

35.4m35.4m105.3m105.3m105.3m105.3m

Total Assets

111.9m158.4m273.1m276.4m267.7m356.8m

Accounts Payable

8.6m7.6m12.7m10.7m12.4m9.7m

Short-term debt

Current Liabilities

26.7m25.6m31.6m28.8m31.9m40.2m

Long-term debt

23.9m24.1m35.6m

Total Debt

23.9m24.1m35.6m

Total Liabilities

86.4m108.0m106.5m107.4m

Additional Paid-in Capital

194.9m271.3m352.9m367.9m387.0m496.5m

Retained Earnings

(122.2m)(138.4m)(165.6m)(199.0m)(225.9m)(247.0m)

Total Equity

72.6m132.5m186.7m168.4m161.2m249.4m

Debt to Equity Ratio

0.1 x0.1 x

Debt to Assets Ratio

0.1 x0.1 x

Financial Leverage

1.5 x1.2 x1.5 x1.6 x1.7 x1.4 x

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Cash

25.8m68.6m42.0m35.5m23.6m30.0m28.7m20.8m19.9m16.1m19.2m21.0m19.4m21.2m13.9m18.0m20.7m25.2m

Inventories

7.1m11.1m12.7m14.6m15.1m16.1m16.6m19.0m19.3m19.0m18.8m19.9m22.6m22.6m21.7m22.3m24.1m24.4m

Current Assets

48.6m107.2m92.8m90.7m93.4m90.7m84.1m65.4m86.5m84.4m79.1m81.1m82.1m84.8m86.8m88.4m155.0m146.5m

PP&E

4.1m5.8m6.5m9.8m13.9m19.4m27.5m31.2m30.9m30.7m29.9m30.0m29.3m28.5m28.1m28.0m27.1m28.1m

Goodwill

35.4m35.4m35.4m35.4m35.4m35.4m105.3m105.3m105.3m105.3m105.3m105.3m105.3m105.3m105.3m105.3m105.3m

Total Assets

57.6m158.6m155.9m157.1m153.4m159.3m165.6m261.7m281.5m279.3m266.4m268.5m268.5m269.7m270.8m272.0m338.4m343.1m

Accounts Payable

5.7m7.9m7.5m7.8m9.7m9.3m11.2m12.8m11.9m11.0m11.3m11.7m10.8m11.6m9.7m10.6m10.4m12.6m

Current Liabilities

16.3m16.0m16.9m21.9m24.6m30.1m39.1m26.2m25.2m26.5m28.4m31.7m36.1m26.9m27.4m33.7m35.5m39.4m

Long-term debt

4.9m25.0m25.0m22.2m20.4m18.7m39.3m39.4m38.6m32.7m33.9m

Total Debt

4.9m25.0m25.0m22.2m20.4m18.7m39.3m39.4m38.6m32.7m33.9m

Total Liabilities

21.4m24.3m21.7m22.1m24.8m30.6m40.2m80.7m104.5m105.9m105.6m107.0m109.5m116.6m111.2m108.2m99.1m101.6m

Additional Paid-in Capital

153.4m264.3m267.0m268.7m273.0m277.8m280.7m356.6m361.0m364.2m370.4m377.6m382.2m389.0m396.1m407.4m492.2m498.4m

Retained Earnings

(117.2m)(129.9m)(132.6m)(133.1m)(143.7m)(148.6m)(154.7m)(175.4m)(183.6m)(190.3m)(209.2m)(216.0m)(223.3m)(236.0m)(236.3m)(243.6m)(252.6m)(256.7m)

Total Equity

36.2m134.3m134.2m135.0m128.6m128.7m125.5m181.0m177.0m173.4m160.9m161.5m158.9m153.1m159.7m163.8m239.3m241.5m

Debt to Equity Ratio

0.1 x0.1 x0.1 x0.1 x0.1 x0.1 x0.3 x0.2 x0.2 x

Debt to Assets Ratio

0.1 x0.1 x0.1 x0.1 x0.1 x0.1 x0.1 x0.1 x0.1 x

Financial Leverage

1.6 x1.2 x1.2 x1.2 x1.2 x1.2 x1.3 x1.4 x1.6 x1.6 x1.7 x1.7 x1.7 x1.8 x1.7 x1.7 x1.4 x1.4 x

AtriCure Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(11.5m)(16.2m)(27.2m)(33.3m)(26.9m)(21.1m)

Depreciation and Amortization

2.0m4.8m6.3m9.3m9.1m8.8m

Accounts Receivable

(1.2m)(4.2m)(900.0k)(2.0m)(1.5m)(2.8m)

Inventories

(2.3m)(4.3m)(2.9m)(79.0k)(4.5m)(146.0k)

Accounts Payable

1.4m(944.0k)4.0m(1.1m)1.3m(2.4m)

Cash From Operating Activities

(5.2m)(21.6m)(7.8m)(15.1m)(8.9m)(4.2m)

Purchases of PP&E

(9.2m)(13.4m)(7.7m)(6.4m)(6.2m)

Cash From Investing Activities

(14.2m)(30.6m)(10.5m)(12.1m)3.8m(85.4m)

Cash From Financing Activities

26.8m65.9m14.0m27.7m2.8m100.2m

Interest Paid

473.0k115.0k232.0k1.5m2.0m3.9m

Income Taxes Paid

30.0k146.0k20.0k30.0k37.0k65.0k

AtriCure Ratios

USDY, 2019

EV/EBIT

-267 x

EV/CFO

-105.8 x

Financial Leverage

1.4 x

AtriCure Employee Rating

3.926 votes
Culture & Values
4.2
Work/Life Balance
3.7
Senior Management
3.4
Salary & Benefits
3.9
Career Opportunities
3.3
Source